MEF2B.md
... ...
@@ -22,7 +22,6 @@ timeline
22 22
|Entity|Tier|Description |
23 23
|:------:|:----:|--------------------------------------|
24 24
|![MCL](images/icons/MCL_tier2.png)|2|relevance in MCL not firmly established[@beaLandscapeSomaticMutations2013]|
25
-|![BL](images/icons/BL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous |
26 25
|![DLBCL](images/icons/DLBCL_tier1.png) |1-a | aSHM target and high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]|
27 26
|![FL](images/icons/FL_tier1.png) |1-a | aSHM target and high-confidence FL gene [@morinFrequentMutationHistonemodifying2011]|
28 27
... ...
@@ -101,6 +100,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/M
101 100
<!-- DLBCL: morinFrequentMutationHistonemodifying2011 -->
102 101
<!-- MCL: beaLandscapeSomaticMutations2013 -->
103 102
<!-- FL: morinFrequentMutationHistonemodifying2011 -->
104
-<!-- BL: 2 -->
105 103
106 104
## References
NRXN2.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|--------------------------------------|
22
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC|
22
+|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
PRDM1.md
... ...
@@ -17,7 +17,6 @@ timeline
17 17
18 18
|Entity|Tier|Description |
19 19
|:------:|:----:|--------------------------------------|
20
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
21 20
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@pasqualucciInactivationPRDM1BLIMP12006a]|
22 21
23 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
RAC2.md
... ...
@@ -20,7 +20,6 @@ timeline
20 20
|:------:|:----:|-----------------------------------------|
21 21
|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@hubschmannMutationalMechanismsShaping2021b]|
22 22
23
-|![BL](images/icons/BL_tier2.png)|2|relevance in BL not firmly established|
24 23
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 24
26 25
|Entity|source |frequency (%)|
TET2.md
... ...
@@ -20,7 +20,6 @@ timeline
20 20
|:------:|:----:|--------------------------------------|
21 21
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@albuquerqueEnhancingKnowledgeDiscovery2017a]|
22 22
23
-|![BL](images/icons/BL_tier2.png)|2|relevance in BL not firmly established|
24 23
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 24
26 25
|Entity|source |frequency (%)|